Beam Appoints Eric Foster as Chief Commercial Officer

Company: Beam Therapeutics · Event Type: Executive Appointment · New CCO: Eric Foster · Context: Potential 2027 Risto-cel Launch · Date: September 1, 2026 Summary Beam Therapeutics appointed Eric Foster as chief commercial officer to lead commercial organization and strategy across its hematology and genetic-disease…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *